These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2516566)

  • 1. Effectiveness and plasma levels of sodium valproate monotherapy in the treatment of epilepsies in children: a further study.
    Shirai H; Miura H; Sunaoshi W
    Jpn J Psychiatry Neurol; 1989 Sep; 43(3):517-8. PubMed ID: 2516566
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose sodium valproate therapy for childhood refractory epilepsy.
    Amano R; Mizukawa M; Ohtsuka Y; Ohtahara S
    Jpn J Psychiatry Neurol; 1990 Jun; 44(2):343-4. PubMed ID: 2124287
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of generalized epilepsies with long-term EEG guided single dose administration of sodium valproate].
    Stefan H; Hoffmann F; Fichsel H; Burr W; Bülau P; Fröscher W; Penin H
    Nervenarzt; 1983 Aug; 54(8):430-4. PubMed ID: 6413868
    [No Abstract]   [Full Text] [Related]  

  • 4. A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy.
    Callaghan N; Kenny RA; O'Neill B; Crowley M; Goggin T
    J Neurol Neurosurg Psychiatry; 1985 Jul; 48(7):639-44. PubMed ID: 3928820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of valproate monotherapy on spike-wave activity in generalized epilepsies (author's transl)].
    Stefan H; Hoffmann F; Burr W; Fröscher W; Penin H
    Nervenarzt; 1981 Dec; 52(12):707-14. PubMed ID: 6798478
    [No Abstract]   [Full Text] [Related]  

  • 6. [A single daily dose with valproic acid. A pharmacodynamic and clinical study].
    Pelzl G; Mamoli B
    Wien Klin Wochenschr; 1992; 104(10):286-9. PubMed ID: 1604872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative EEG effects and plasma concentration of sodium valproate: acute and long-term administration to epileptic patients.
    Sannita WG; Gervasio L; Zagnoni P
    Neuropsychobiology; 1989; 22(4):231-5. PubMed ID: 2518602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic study of slow-release preparation of sodium valproate (KW-6066N): multiple dose administration test and the steady-state serum level profiles in epileptic patients.
    Takeda A; Hishida H; Amioka K; Sakamoto Y; Terao S; Ishikawa S; Aoki H
    Jpn J Psychiatry Neurol; 1989 Sep; 43(3):515-6. PubMed ID: 2516565
    [No Abstract]   [Full Text] [Related]  

  • 9. The long-term effectiveness of clonazepam therapy in the control of partial seizures in children difficult to control with carbamazepine monotherapy.
    Hosoda N; Miura H; Takanashi S; Shirai H; Sunaoshi W
    Jpn J Psychiatry Neurol; 1991 Jun; 45(2):471-3. PubMed ID: 1762251
    [No Abstract]   [Full Text] [Related]  

  • 10. Sodium valproate monotherapy in childhood epilepsy.
    Dulac O; Steru D; Rey E; Perret A; Arthuis M
    Brain Dev; 1986; 8(1):47-52. PubMed ID: 3085530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A trial of once-daily administration of KW6066N for patients with benign rolandic and primary generalized epilepsy.
    Kugoh T; Hosokawa K; Kashihara K
    Jpn J Psychiatry Neurol; 1988 Sep; 42(3):580-2. PubMed ID: 3149373
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term prognosis of epileptic children with partial seizures treated with carbamazepine monotherapy.
    Sunaoshi W; Miura H; Shirai H; Hosoda N
    Jpn J Psychiatry Neurol; 1990 Jun; 44(2):346-8. PubMed ID: 2124288
    [No Abstract]   [Full Text] [Related]  

  • 13. An observational study of first-line valproate monotherapy in focal epilepsy.
    Jedrzejczak J; Kuncíková M; Magureanu S;
    Eur J Neurol; 2008 Jan; 15(1):66-72. PubMed ID: 18042239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.
    Trinka E; Marson AG; Van Paesschen W; Kälviäinen R; Marovac J; Duncan B; Buyle S; Hallström Y; Hon P; Muscas GC; Newton M; Meencke HJ; Smith PE; Pohlmann-Eden B;
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1138-47. PubMed ID: 22933814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma concentrations of sodium valproate: their clinical value.
    Turnbull DM; Rawlins MD; Weightman D; Chadwick DW
    Ann Neurol; 1983 Jul; 14(1):38-42. PubMed ID: 6412620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled study with taltrimide and sodium valproate: valproate effective in partial epilepsy.
    Iivanainen M; Waltimo O; Tokola O; Parantainen J; Tamminen M; Allonen H; Neuvonen PJ
    Acta Neurol Scand; 1990 Aug; 82(2):121-5. PubMed ID: 2124033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of slow-release preparations of sodium valproate.
    Yamatogi Y; Yoshinaga H; Oka E; Ohtahara S; Yamashita S; Furuno K; Gomita Y
    Psychiatry Clin Neurosci; 1995 Dec; 49(5-6):309-10. PubMed ID: 8726120
    [No Abstract]   [Full Text] [Related]  

  • 18. Expanded therapeutic range of valproate.
    Hurst DL
    Pediatr Neurol; 1987; 3(6):342-4. PubMed ID: 3149476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproate monotherapy in the management of generalized and partial seizures.
    Chadwick DW
    Epilepsia; 1987; 28 Suppl 2():S12-7. PubMed ID: 3121291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of monotherapy with valproate and other antiepileptic drugs in the treatment of seizure disorders.
    Chadwick D
    Am J Med; 1988 Jan; 84(1A):3-6. PubMed ID: 3146223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.